Access Purchased Content

Addiction Treatment
Addiction Treatment RSS Feed RSS

Inhalants: An Invisible Danger

September 10, 2021
Michael Weaver, MD, FASAM,
Michael Weaver, MD, FASAM, Professor and medical director at the Center for Neurobehavioral Research on Addictions at the University of Texas Medical School. Dr. Weaver has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity
Inhalants are easily available household chemicals that can create short-lived intoxicating effect in users. Unfortunately, serious long term side effects can result from their use. We review the effects that inhalants can have the body and cover screening and treatment options.
Read More

The Continuing Challenge of Designer Drugs

September 10, 2021
Marilyn A. Huestis, PhD
Marilyn A. Huestis, PhDMarilyn A. Huestis, PhD

Senior fellow at the Institute on Emerging Health Professions, Thomas Jefferson University. Former Chief of the Chemistry and Drug Metabolism Section, IRP, National Institute on Drug Abuse (NIA). Dr. Huestis has disclosed that she has received payment as a consultant for Dynacare Laboratories, which provides lab testing.

Dr. Capurso has reviewed this article and found no evidence of bias in this educational activity.

Designer drugs is a catchall term for a large group of illicit substances that can have disparate effects. Dr. Huestis provides an in depth look at the current state of designer drugs, what clinicians should be wary of, and treatment options.
Read More

Misuse of Over-the-Counter Medications

September 10, 2021
Amy Ton, MD, and Deepti Anbarasan, MD
Amy Ton, MD, resident in psychiatry, New York University, New York, NY. Deepti Anbarasan, MD, associate professor in psychiatry & neurology, New York University. Dr. Ton and Dr. Anbarasan have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Over the counter medications are commonly misused, particularly among younger patients. Dextromethorphan, first generation antihistamines, and nasal decongestants are the most frequently encountered. We cover the clinical features of each and discuss treatment strategies.
Read More

Breastfeeding and Addiction

July 3, 2021
Pochu Ho, MD.
Pochu Ho, MD. Assistant Professor of Psychiatry, Yale University. Director of Psychiatric Consultation Service, West Haven VA Medical Center, CT. Dr. Ho has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Addictive substances and medications alike can find their way into the breastmilk of lactating women, however the effect these substances have on breastfeeding babies can vary. We provide guidance on how best to manage addiction in women who are actively breastfeeding.
Read More

The Pregnant Patient With Substance Use Disorder

July 3, 2021
Ariadna Forray, MD
Ariadna Forray, MDAriadna Forray, MD
Associate Professor of Psychiatry, Yale School of Medicine, New Haven, CT. Interim Chief, Section of Psychological Medicine. Director, Center for Wellbeing of Women and Mothers, Yale New Haven Hospital. Dr. Forray has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Dr. Forray gives readers a comprehensive refresher on fetal effects of alcohol, tobacco, opioid, cannabis, and stimulant use during pregnancy. She then lays out the current evidence for various treatments and provides recommendations for how to treat pregnant patients with addiction.
Read More

Naloxone Prescribing

July 3, 2021
Phillip Coffin, MD
Phillip Coffin, MDPhillip Coffin, MD
Director of Substance Use Research, San Francisco Department of Public Health, San Francisco, CA. Dr. Coffin has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Dr. Coffin provides our readers with everything there is to know about the nuts and bolts of naloxone prescribing for opioid use disorder. He tells us how patients can get their hands on naloxone, reviews the pros, cons, and costs of various naloxone formulations, and covers current naloxone laws.
Read More

A New High-Dose Naloxone: Life Saver or Punishment?

July 3, 2021
Noah Capurso, MD
Noah Capurso, Editor-in-ChiefNoah Capurso, MD 

Dr. Capurso has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.


The FDA recently approved a nasal spray formulation of naloxone. Called Kloxxado, each spray delivers 8mg, twice as much as the most widely used formulation, Narcan. Whether or not this higher dose is necessary, is debatable.
Read More

Does CBT Enhance Pharmacotherapy for Addiction?

July 3, 2021
Jedidiah Perdue, MD, MPH
Jedidiah Perdue, MD, MPH Dr. Perdue has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Psychotherapy has had a mixed track record of efficacy for substance use disorders. This meta-analysis suggests that CBT is only modestly effective when combined with medications and likely no better than any other form of therapy. Although it’s unlikely be a magic bullet, CBT is very low risk, and reasonable to offer alongside other more established treatments.
Read More
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
Featured Video
Featured Podcast
Recommended

About

Shop Online

Newsletters

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.